PDF herunterladen
CC BY-NC-ND 4.0 · J Lab Physicians 2015; 7(01): 038-042
DOI: 10.4103/0974-2727.151699
Original Article

Magnitude of Enterococcal Bacteremia in Trauma Patients Admitted for Intensive Trauma Care: A Tertiary Care Experience from South Asian Country

Nonika Rajkumari
Department of Laboratory Medicine, Division of Microbiology, Jai Prakash Narayan Apex Trauma Centre, All India Institute of Medical Sciences, New Delhi, India
,
Purva Mathur
Department of Laboratory Medicine, Division of Microbiology, Jai Prakash Narayan Apex Trauma Centre, All India Institute of Medical Sciences, New Delhi, India
,
Bariamtak Thanbuana
Hospital infection Control, Jai Prakash Narayan Apex Trauma Centre, All India Institute of Medical Sciences, New Delhi, India
,
Swaminathan Sajan
Hospital infection Control, Jai Prakash Narayan Apex Trauma Centre, All India Institute of Medical Sciences, New Delhi, India
,
Mahesh C Misra
Department of Surgical Disciplines, All India Institute of Medical Sciences, New Delhi, India
› Institutsangaben Source of Support: Nil.
› Weitere Informationen
Auch verfügbar auf
  als PDF herunterladen Lizenzen und Reprints

ABSTRACT

Background: Bloodstream infection (BSI) and bacteremias due to Enterococcus spp. are increasing worldwide with the current need to understand its causes among hospitalized trauma patients. Hence, the study was conducted.

Methodology: A 3-year retrospective laboratory cum clinical based study was performed at a level I trauma center in India. Patients with health care associated enterococcal bacteremia were identified using the hospital database, their episodes of BSI/bacteremia calculated and their clinical records and treatment were noted.

Results: A total of 104 nonrepetitive Enterococcus spp. was isolated of which Enterococcus faecium was the most common (52%). High-level resistance to gentamicin high-level aminoglycoside resistance was seen in all the Enterococcus spp. causing bacteremia, whereas a low resistance to vancomycin and teichoplanin was observed. Overall mortality was more in patients infected with vancomycin-resistant Enterococcus (5/11, 46%) compared to those with vancomycin sensitive Enterococcus (9/93, 10%); though no significant association of mortality with Enterococcus spp. bacteremia (P > 0.05) was seen. The rate of bacteremia due to Enterococcus spp. was 25.4 episodes/1,000 admissions (104/4,094) during the study period.

Conclusion: Enterococcal bacteremia is much prevalent in trauma care facilities. Here, a microbiologist can act as a sentinel and help in preventing such infections.

Key words

Bacteremia - drug resistance - Enterococcus sp. - trauma - vancomycin-resistant Enterococcus


Publikationsverlauf

Artikel online veröffentlicht:
19. April 2020

© 2015.

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • REFERENCES

  • 1 Bonten MJ, Willems R, Weinstein RA. Vancomycin-resistant enterococci: Why are they here, and where do they come from? Lancet Infect Dis 2001;1:314-25.
  • 2 Tripathi A, Shukla SK, Singh A, Prasad KN. A new approach of real time polymerase chain reaction in detection of vancomycin-resistant enterococci and its comparison with other methods. Indian J Med Microbiol 2013;31:47-52.
  • 3 Cheah AL, Spelman T, Liew D, Peel T, Howden BP, Spelman D, et al. Enterococcal bacteraemia: Factors influencing mortality, length of stay and costs of hospitalization. Clin Microbiol Infect 2013;19:E181-9.
  • 4 McComb MN, Collins CD. Comparative cost-effectiveness of alternative empiric antimicrobial treatment options for suspected enterococcal bacteremia. Pharmacotherapy 2014;34:537-44.
  • 5 Coombs GW, Pearson JC, Daley DA, Le T, Robinson OJ, Gottlieb T, et al. Molecular epidemiology of enterococcal bacteremia in Australia. J Clin Microbiol 2014;52:897-905.
  • 6 Pinholt M, Ostergaard C, Arpi M, Bruun NE, Schønheyder HC, Gradel KO, et al. Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006-2009: A population-based cohort study. Clin Microbiol Infect 2014;20:145-51.
  • 7 Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39:309-17.
  • 8 Fluit AC, Schmitz FJ, Verhoef J, European SENTRY Participant Group. Frequency of isolation of pathogens from bloodstream, nosocomial pneumonia, skin and soft tissue, and urinary tract infections occurring in European patients. Eur J Clin Microbiol Infect Dis 2001;20:188-91.
  • 9 Barnaud G, Bingen E. Genotypic characterisation of endemic VanA Enterococcus faecium strains isolated in a paediatric hospital. J Med Microbiol 2000;49:793-9.
  • 10 Mathur P, Kapil A, Chandra R, Sharma P, Das B. Antimicrobial resistance in Enterococcus faecalis at a tertiary care centre of northern India. Indian J Med Res 2003;118:25-8.
  • 11 Rajkumari N, Mathur P, Sharma S, Gupta B, Bhoi S, Misra MC. Procalcitonin as a predictor of sepsis and outcome in severe trauma patients: A prospective study. J Lab Physicians 2013;5:100-8.
  • 12 Baron EJ, Weinstein MP, Dunne WM, Yagupsky P, Welch DF, Wilson DM. In: Yagupsky P, Welch DF, Wilson DM, editors. Blood Cultures IV. Washington DC: American Society for Microbiology; 2005.
  • 13 Collee JG, Miles RS, Watt B. Tests for the identification of bacteria. In: Collee JG, Fraser AG, Marmion BP, Simmons A, editors. Mackie and McCartney Practical Medical Microbiology. 14th ed. New York: Churchill Livingstone; 1996. p. 131-45.
  • 14 Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-40.
  • 15 Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007;298:1763-71.
  • 16 Klevens RM, Morrison MA, Fridkin SK, Reingold A, Petit S, Gershman K, et al. Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerg Infect Dis 2006;12:1991-3.
  • 17 Rodriguez-Creixems M, Munoz P, Martin-Rabadan P, Cercenado M, Guembe M, Bouza E. Evolution and aetiological shift of catheter-related bloodstream infection in a whole institution: The microbiology department may act as a watchdog. Clin Microbiol Infect 2013;19:845-51.
  • 18 CLSI. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Wayne, PA: Approved Guideline-Second Edition; 2010. p. M45-A2.
  • 19 CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Clinical and Laboratory Standard Institute (CLSI) document. Wayne, PA, USA: Clinical and Laboratory Standards Institute; 2012. p. M100-S22.
  • 20 Matuschek E, Brown DF, Kahlmeter G. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories. Clin Microbiol Infect 2014;20:O255-66.
  • 21 Weisser M, Capaul S, Dangel M, Elzi L, Kuenzli E, Frei R, et al. Additive effect of Enterococcus faecium on enterococcal bloodstream infections: A 14-year study in a Swiss tertiary hospital. Infect Control Hosp Epidemiol 2013;34:1109-12.
  • 22 Cho SY, Lee DG, Choi SM, Kwon JC, Kim SH, Choi JK, et al. Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: A retrospective study. BMC Infect Dis 2013;13:504.
  • 23 Reigadas E, Rodríguez-Cré;ixems M, Guembe M, Sánchez-Carrillo C, Martín-Rabadán P, Bouza E. Catheter-related bloodstream infection caused by Enterococcus spp. Clin Microbiol Infect 2013;19:457-61.
  • 24 Gudiol C, Ayats J, Camoez M, Domínguez MÁ, García-Vidal C, Bodro M, et al. Increase in bloodstream infection due to vancomycin-susceptible Enterococcus faecium in cancer patients: Risk factors, molecular epidemiology and outcomes. PLoS One 2013;8:e74734.